One of the strengths of our study is the fact that we evaluated, in women with PCOS, not only the role of the rs738409 PNPLA3 polymorphism in the risk of NAFLD and its progressive forms but also its interaction with other metabolic and endocrine factors. This evidence concerns the gene PNPLA3 and polycystic ovary syndrome.